Table 2 Demographic characteristics according to the inflammatory phenotype
| Â | Paucigranulocytic phenotype | Eosinophilic phenotype | Neutrophilic phenotype | Mixed granulocytic phenotype |
|---|---|---|---|---|
N. | 203 (40%) | 211 (41.5%) | 80 (15.7%) | 14 (2.8%) |
Sex (M/F) | 72/131 | 101/110* | 21/59 | 7/7 |
Age, yrs | 51 (21–86) | 51 (19–87) | 57 (21–84) | 68 (31–88) |
Atopy (Y/N) | 100/103 (49%) | 140/71 (66%)* | 48/32 (60%) | 8/6 (57%) |
Smoking (Y/N) | 48/155 (23%) | 38/173 (18%) | 12/68 (15%) | 3/11 (21%) |
ICS therapy | Â | Â | Â | Â |
-Steroid naïve | 66 (32.5%) | 59 (28%) | 25 (31.3%) | 3 (21.4%) |
-Low dose | 31 (15.3%) | 37 (17.5%) | 4 (5%)* | 1 (7.2%) |
-Moderate dose | 58 (28.6%) | 54 (25.6%) | 23 (28.7%) | 3 (21.4%) |
-High dose | 48 (23.6%) | 61 (28.9%) | 28 (35%) | 7 (50%) |